Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)
Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –
Eton Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Eton Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was 28.8%. For fiscal 2025 it was -1.1%, against -6.7% the year before. The highest annual figure on record is -1.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.1% | +5.6 |
| FY2024 | Dec 31, 2024 | -6.7% | −2.9 |
| FY2023 | Dec 31, 2023 | -3.8% | +35.1 |
| FY2022 | Dec 31, 2022 | -38.9% | −32.0 |
| FY2021 | Dec 31, 2021 | -6.8% | +69508.5 |
| FY2020 | Dec 31, 2020 | -69515.4% | −67575.8 |
| FY2019 | Dec 31, 2019 | -1939.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 39.7% | +45.8 |
| Q2 FY2026 | Jun 30, 2026 | 34.0% | +41.8 |
| Q1 FY2026 | Mar 31, 2026 | 9.9% | +12.7 |
| Q4 FY2025 | Dec 31, 2025 | 11.6% | +6.2 |
| Q3 FY2025 | Sep 30, 2025 | -6.1% | −11.0 |
| Q2 FY2025 | Jun 30, 2025 | -7.8% | +24.6 |
| Q1 FY2025 | Mar 31, 2025 | -2.7% | +7.3 |
| Q4 FY2024 | Dec 31, 2024 | 5.4% | +32.7 |
| Q3 FY2024 | Sep 30, 2024 | 4.9% | +12.7 |
| Q2 FY2024 | Jun 30, 2024 | -32.3% | −64.7 |
| Q1 FY2024 | Mar 31, 2024 | -10.0% | +37.7 |
| Q4 FY2023 | Dec 31, 2023 | -27.3% | −39.7 |
| Q3 FY2023 | Sep 30, 2023 | -7.8% | +82.1 |
| Q2 FY2023 | Jun 30, 2023 | 32.4% | +50.6 |
| Q1 FY2023 | Mar 31, 2023 | -47.8% | +186.0 |
| Q4 FY2022 | Dec 31, 2022 | 12.5% | −9.1 |
| Q3 FY2022 | Sep 30, 2022 | -89.9% | +664.5 |
| Q2 FY2022 | Jun 30, 2022 | -18.2% | +57.6 |
| Q1 FY2022 | Mar 31, 2022 | -233.8% | −278.9 |
| Q4 FY2021 | Dec 31, 2021 | 21.6% | +9182.1 |
| Q3 FY2021 | Sep 30, 2021 | -754.5% | +21935.5 |
| Q2 FY2021 | Jun 30, 2021 | -75.8% | +8894.9 |
| Q1 FY2021 | Mar 31, 2021 | 45.1% | +623.7 |
| Q4 FY2020 | Dec 31, 2020 | -9160.5% | −7649.7 |
| Q2 FY2020 | Jun 30, 2020 | -22690.0% | – |
| Q1 FY2020 | Mar 31, 2020 | -8970.7% | – |
| Q4 FY2019 | Dec 31, 2019 | -578.6% | – |
| Q1 FY2019 | Mar 31, 2019 | -1510.8% | – |
See a number that looks wrong?